The comparative effects of long-term carvedilol versus bisoprolol therapy on QT dispersion in patients with chronic heart failure

Cardiology

Volumn 112, Issue 3, 2009, Pages 168-173

  Aygul, Nazif ^a   Ozdemir, Kurtulus ^a   Duzenli, Mehmet Akif ^a   Aygul, Meryem Ulku ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Bisoprolol; Carvedilol; Chronic heart failure; QT dispersion

Indexed keywords

BISOPROLOL; CARVEDILOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART RATE; HEART VENTRICLE EJECTION; HUMAN; MALE; PRIORITY JOURNAL; QT DISPERSION; RANDOMIZED CONTROLLED TRIAL;

ADRENERGIC BETA-ANTAGONISTS; AGED; BISOPROLOL; CARBAZOLES; CHRONIC DISEASE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PROPANOLAMINES; STROKE VOLUME;

EID: 47649105169     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000147950     Document Type: Article

References (32)

1. Mozaffarian D, Anker SD, Anand I, Linker DT, Sullivan MD, Cleland JG, Carson PE, Maggioni AP, Mann DL, Pitt B, Poole-Wilson PA, Levy WC: Prediction of mode of death in heart failure: the Seattle Heart Failure Model. Circulation 2007;116:392-398.
2. Olshansky B, Wood F, Hellkamp AS, Poole JE, Anderson J, Johnson GW, Boineau R, Domanski MJ, Mark DB, Lee KL, Bardy GH; SCD-HeFT Investigators: Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J 2007;153:1089-1094.
3. Padmanabhan S, Silvet H, Amin J, Pai RG: Prognostic value of QT interval and QT dispersion in patients with left ventricular systolic dysfunction: results from a cohort of 2265 patients with an ejection fraction of < or =40%. Am Heart J 2003;145:132-138.
4. Okin PM, Devereux RB, Howard BV, Fabsitz RR, Lee ET, Welty TK: Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: The Strong Heart Study. Circulation 2000;101:61-66.
5. Galinier M, Vialette JC, Fourcade J, Cabrol P, Dongay B, Massabuau P, Boveda S, Doazan JP, Fauvel JM, Bounhoure JP: QT interval dispersion as a predictor of arrhythmic events in congestive heart failure. Importance of aetiology. Eur Heart J 1998;19:1054-1062.
6. Kearney MT, Fox KA, Lee AJ, Brooksby WP, Shah AM, Flapan A, Prescott RJ, Andrews R, Batin PD, Eckberg DL, Gall N, Zaman AG, Lindsay HS, Nolan J: Predicting sudden death in patients with mild to moderate chronic heart failure. Heart 2004;90:1137-1143.
7. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. CIBIS-II Investigators and Committees. Lancet 1999;353:9-13.
8. de Groote P, Delour P, Mouquet F, Lamblin N, Dagorn J, Hennebert O, Le Tourneau T, Foucher-Hossein C, Verkindère C, Bauters C: The effects of beta-blockers in patients with stable chronic heart failure. Predictors of left ventricular ejection fraction improvement and impact on prognosis. Am Heart J 2007;154:589-595.
9. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Roecker EB, Schultz MK, DeMets DL; Carvedilol Prospective Randomized Cumulative Survival Study Group: Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651-1658.
10. Fesmire SI, Marcoux LG, Lyyski DS, Sprague MK, Kennedy HL, Eichhorn EJ: Effect of selective versus nonselective beta blockade on QT dispersion in patients with nonischemic dilated cardiomyopathy. Am J Cardiol 1999;84:350-354.
11. Peng DQ, Zhao SP, Chen Y, Li XP: Effect of bisoprolol on QT dispersion in patients with congestive heart failure - the etiology-dependent response. Int J Cardiol 2001;77:141-148.
12. Yildirir A, Sade E, Tokgozoglu L, Oto A: The effects of chronic carvedilol therapy on QT dispersion in patients with congestive heart failure. Eur J Heart Fail 2001;3:717-721.
13. Pittenger B, Gill EA, Holcslaw TL, Bristow MR: Relation of dose of carvedilol to reduction in QT dispersion in patients with mild to moderate heart failure secondary to ischemic or to idiopathic dilated cardiomyopathy. Am J Cardiol 2004;94:1459-1462.
14. Akdeniz B, Guneri S, Savas IZ, Aslan O, Baris N, Badak O, Kirimli O, Göldeli O: Effects of carvedilol therapy on arrhythmia markers in patients with congestive heart failure. Int Heart J 2006;47:565-573.
15. Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, Lubsen J, Lutiger B, Metra M, Remme WJ, Torp-Pedersen C, Scherhag A, Skene A; Carvedilol Or Metoprolol European Trial Investigators: Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 2003;362:7-13.
16. Maack C, Elter T, Nickenig G, LaRosee K, Crivaro M, Stäblein A, Wuttke H, Böhm M: Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure. J Am Coll Cardiol 2001;38:939-946.
17. Bonnar CE, Davie AP, Caruana L, Fenn L, Ogston SA, McMurray JJ, Struthers AD: QT dispersion in patients with chronic heart failure: beta blockers are associated with a reduction in QT dispersion. Heart 1999;81:297-302.
18. Stoletniy LN, Pai SM, Platt ML, Torres VI, Pai RG: QT dispersion as a noninvasive predictor of inducible ventricular tachycardia. J Electrocardiol 1999;32:173-177.
19. Gang Y, Ono T, Hnatkova K, Hashimoto K, Camm AJ, Pitt B, Poole-Wilson PA, Malik M; ELITE II investigators: QT dispersion has no prognostic value in patients with symptomatic heart failure: an ELITE II substudy. Pacing Clin Electrophysiol 2003;26:394-400.
20. Fauchier L, Douglas J, Babuty D, Cosnay P, Fauchier JP: QT dispersion in nonischemic dilated cardiomyopathy. A long-term evaluation. Eur J Heart Fail 2005;7:277-282.
21. Barr CS, Naas A, Freeman M, Lang CC, Struthers AD: QT dispersion and sudden unexpected death in chronic heart failure. Lancet 1994;343:327-329.
22. Anastasiou-Nana MI, Nanas JN, Karagounis LA, Tsagalou EP, Alexopoulos GE, Toumanidis S, Gerali S, Stamatelopoulos SF, Moulopoulos SD: Relation of dispersion of QRS and QT in patients with advanced congestive heart failure to cardiac and sudden death mortality. Am J Cardiol 2000;85:1212-1217.
23. Yee KM, Struthers AD: Can drug effects on mortality in heart failure be predicted by any surrogate measure? Eur Heart J 1997;18:1860-1864.
24. Mesquita ET, Deus FC, Guedes CR, Maia ER, Subieta CG, Villacorta H, Santos PA, Cramer H, Santos VB, Romeo LJ: Effects of propranolol on the QT dispersion in congestive heart failure. Arq Bras Cardiol 1999;73:295-298.
25. Galetta F, Franzoni F, Magagna A, Femia FR, Pentimone F, Santoro G, Carpi A: Effect of nebivolol on QT dispersion in hypertensive patients with left ventricular hypertrophy. Biomed Pharmacother 2005;59:15-19.
26. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees. Circulation 1994;90:1765-1773.
27. Bonnemeier H, Ortak J, Tölg R, Witt M, Schmidt J, Wiegand UK, Bode F, Schunkert H, Richardt G: Carvedilol versus metoprolol in patients undergoing direct percutaneous coronary interventions for myocardial infarction: effects on QT dynamicity. Pacing Clin Electrophysiol 2005;28:S217-S221.
28. Hamaad A, Lip GY, Nicholls D, MacFadyen RJ: Comparative dose titration responses to the introduction of bisoprolol or carvedilol in stable chronic systolic heart failure. Cardiovasc Drugs Ther 2007;21:437-444.
29. Stoschitzky K, Stoschitzky G, Brussee H, Bonelli C, Dobnig H: Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol. Cardiology 2006;106:199-206.
30. Kukin ML, Kalman J, Charney RH, Levy DK, Buchholz-Varley C, Ocampo ON, Eng C: Antioxidant effect of carvedilol and metoprolol in congestive heart failure (abstract). J Am Coll Cardiol 1998;31:189A.
31. di Bernardo D, Langley P, Murray A: Dispersion of QT intervals: a measure of dispersion of repolarization or simply a projection effect? Pacing Clin Electrophysiol 2000;23:1392-1396.
32. Faber TS, Kautzner J, Zehender M, Camm AJ, Malik M: Impact of electrocardiogram recording format on QT interval measurement and QT dispersion assessment. Pacing Clin Electrophysiol 2001;24:1739-1747.